Publications

Below you can view some of the research we have published.

Nirmatrelvir, Molnupiravir, and Remdesivir maintain potent in vitro activity against the SARS-CoV-2 Omicron variant

Romel Rosales, Briana L. McGovern, M. Luis Rodriguez, Devendra K. Rai, Rhonda D. Cardin, Annaliesa S. Anderson, PSP study group, Emilia Mia Sordillo, Harm van Bakel, Viviana Simon, Adolfo García-Sastre, Kris M. White